Faculty of Medicine, University of Valladolid
Valladolid, 47005, Spain
NCT Number: NCT04985097
This multicentre randomised controlled trial aimed to reduce the visual discomfort that patients implanted with trifocal diffractive intraocular lenses may experience after surgery. To this end, a visual training software (Optictrain) was developed in which Gabor patches were presented to the patient on a hand-held electronic device. Patients who met all inclusion criteria and consented to participate underwent half an hour of visual training per day for a period of 20 consecutive days remotely on a colourimetrically characterised Samsung Galaxy Tab A device on which the Optictrain software (n=30) or a placebo software (n=30), respectively, was pre-installed. Corrected and uncorrected near, intermediate and distance visual acuity (VA) and mesopic near and distance contrast sensitivity (CS) were measured monocularly and binocularly at two visits: during the first postoperative week (V0) and after 20 days of visual training with the assigned software (V1). The statistical analysis of the results obtained in the study has not yet been carried out.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Valladolid, 47005, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Postsurgical monocular and binocular assessment of corrected and uncorrected near, intermediate and distance visual acuity and near and distance mesopic contrast sensitivity before and after the assigned vision training
Time frame: During the first post-operative week and after 20 days of vision training with the randomly assigned software
Monocular and binocular corrected and uncorrected visual acuity under near, intermediate and distance conditions
Time frame: During the first post-operative week and after 20 days of vision training with the randomly assigned software
Monocular and binocular mesopic contrast sensitivity under near and distance conditions
Increase-Tech
Other
Preliminary Evaluation of the Clinical Benefit of a Novel Visual Rehabilitation System in Patients Implanted With Trifocal Diffractive Intraocular Lenses: A Blinded Randomized Placebo-controlled Clinical Trial
Acronym: OPTicTRAIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02147457
Blindness, Cardiovascular Diseases
Eksel, Limburg, Belgium
View Trial DetailsNCT03841734
Arteritis, Arteritis, Giant Cell
Cannes, France
View Trial DetailsNCT00584935
Autoimmune Diseases, Blindness
Birmingham, Alabama, United States
View Trial DetailsNCT04963075
Blindness, Brain Diseases
Winston-Salem, North Carolina, United States
View Trial Details